Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1093728.RA4oK3TSypTZzK5FZaPsZjtv05_ORZTDwxFi_bYNJDzgE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1093728.RA4oK3TSypTZzK5FZaPsZjtv05_ORZTDwxFi_bYNJDzgE130_assertion type Assertion NP1093728.RA4oK3TSypTZzK5FZaPsZjtv05_ORZTDwxFi_bYNJDzgE130_head.
- NP1093728.RA4oK3TSypTZzK5FZaPsZjtv05_ORZTDwxFi_bYNJDzgE130_assertion description "[We show here for the first time that co-treatment in vivo with TRAIL and 17-AAG in two TRAIL-resistant human colorectal cancer xenograft models resulted in significantly greater tumor growth inhibition compared to single treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1093728.RA4oK3TSypTZzK5FZaPsZjtv05_ORZTDwxFi_bYNJDzgE130_provenance.
- NP1093728.RA4oK3TSypTZzK5FZaPsZjtv05_ORZTDwxFi_bYNJDzgE130_assertion evidence source_evidence_literature NP1093728.RA4oK3TSypTZzK5FZaPsZjtv05_ORZTDwxFi_bYNJDzgE130_provenance.
- NP1093728.RA4oK3TSypTZzK5FZaPsZjtv05_ORZTDwxFi_bYNJDzgE130_assertion SIO_000772 23852390 NP1093728.RA4oK3TSypTZzK5FZaPsZjtv05_ORZTDwxFi_bYNJDzgE130_provenance.
- NP1093728.RA4oK3TSypTZzK5FZaPsZjtv05_ORZTDwxFi_bYNJDzgE130_assertion wasDerivedFrom befree-2016 NP1093728.RA4oK3TSypTZzK5FZaPsZjtv05_ORZTDwxFi_bYNJDzgE130_provenance.
- NP1093728.RA4oK3TSypTZzK5FZaPsZjtv05_ORZTDwxFi_bYNJDzgE130_assertion wasGeneratedBy ECO_0000203 NP1093728.RA4oK3TSypTZzK5FZaPsZjtv05_ORZTDwxFi_bYNJDzgE130_provenance.